HEADER TRANSFERASE 06-DEC-06 2O5K TITLE CRYSTAL STRUCTURE OF GSK3BETA IN COMPLEX WITH A BENZOIMIDAZOL TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 22-393; COMPND 5 SYNONYM: GSK-3 BETA; COMPND 6 EC: 2.7.11.26; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: MODIFIED PET21B KEYWDS GSK3BETA, BENZOIMIDAZOL INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.SHIN,S.C.LEE,Y.S.HEO,Y.S.CHO,Y.E.KIM,Y.L.HYUN,J.M.CHO,Y.S.LEE,S.RO REVDAT 3 25-OCT-23 2O5K 1 REMARK SEQADV REVDAT 2 24-FEB-09 2O5K 1 VERSN REVDAT 1 23-OCT-07 2O5K 0 JRNL AUTH D.SHIN,S.C.LEE,Y.S.HEO,W.Y.LEE,Y.S.CHO,Y.E.KIM,Y.L.HYUN, JRNL AUTH 2 J.M.CHO,Y.S.LEE,S.RO JRNL TITL DESIGN AND SYNTHESIS OF 7-HYDROXY-1H-BENZOIMIDAZOLE JRNL TITL 2 DERIVATIVES AS NOVEL INHIBITORS OF GLYCOGEN SYNTHASE JRNL TITL 3 KINASE-3BETA JRNL REF BIOORG.MED.CHEM.LETT. V. 17 5686 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17764934 JRNL DOI 10.1016/J.BMCL.2007.07.056 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 680379.700 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.5 REMARK 3 NUMBER OF REFLECTIONS : 6574 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.240 REMARK 3 FREE R VALUE : 0.309 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.100 REMARK 3 FREE R VALUE TEST SET COUNT : 207 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.021 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1023 REMARK 3 BIN R VALUE (WORKING SET) : 0.2680 REMARK 3 BIN FREE R VALUE : 0.2990 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 31 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.054 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2790 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 14.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -20.82000 REMARK 3 B22 (A**2) : 16.01000 REMARK 3 B33 (A**2) : 4.81000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.44 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.54 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.950 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : OVERALL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.42 REMARK 3 BSOL : 98.57 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : HBI.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : HBI.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURE WAS REFINED ALSO WITH REMARK 3 REFMAC 5.0. REMARK 4 REMARK 4 2O5K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 15-DEC-06. REMARK 100 THE DEPOSITION ID IS D_1000040714. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JAN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : DOUBLE MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6785 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.2 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.39000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1R0E REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES NA, 0.1M PROLINE, 20% REMARK 280 PEG3350, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 35.47000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.89750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.31600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.89750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.47000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.31600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 22 REMARK 465 HIS A 23 REMARK 465 HIS A 24 REMARK 465 HIS A 25 REMARK 465 HIS A 26 REMARK 465 HIS A 27 REMARK 465 HIS A 28 REMARK 465 SER A 29 REMARK 465 ARG A 30 REMARK 465 ASP A 31 REMARK 465 LYS A 32 REMARK 465 ASP A 33 REMARK 465 GLY A 34 REMARK 465 GLN A 385 REMARK 465 ALA A 386 REMARK 465 ALA A 387 REMARK 465 ALA A 388 REMARK 465 SER A 389 REMARK 465 THR A 390 REMARK 465 PRO A 391 REMARK 465 THR A 392 REMARK 465 ASN A 393 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 90 CB CG OD1 OD2 REMARK 470 ARG A 92 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 292 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 300 C - N - CA ANGL. DEV. = 10.7 DEGREES REMARK 500 PRO A 380 C - N - CA ANGL. DEV. = 10.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 44 104.92 -52.06 REMARK 500 PRO A 48 -133.55 -82.91 REMARK 500 ASP A 58 -6.16 72.86 REMARK 500 THR A 59 119.50 -23.43 REMARK 500 ILE A 62 -3.37 -142.08 REMARK 500 SER A 66 -51.04 -20.32 REMARK 500 CYS A 76 -17.13 -48.46 REMARK 500 ASP A 77 -83.52 -95.07 REMARK 500 ASP A 90 -31.40 -35.91 REMARK 500 LYS A 91 -53.00 66.37 REMARK 500 LEU A 104 155.46 -40.55 REMARK 500 ASP A 105 70.28 177.04 REMARK 500 CYS A 107 -4.51 -57.21 REMARK 500 VAL A 110 128.13 -29.24 REMARK 500 GLU A 121 -147.74 -178.36 REMARK 500 LYS A 122 -114.53 57.70 REMARK 500 ASP A 124 65.06 66.60 REMARK 500 PRO A 136 -112.41 -77.48 REMARK 500 GLU A 137 -171.55 -44.92 REMARK 500 ALA A 149 18.45 -145.06 REMARK 500 LYS A 150 23.90 41.69 REMARK 500 GLN A 151 -156.13 -114.86 REMARK 500 TYR A 171 -73.38 -72.13 REMARK 500 ASP A 181 24.99 179.06 REMARK 500 LEU A 187 75.09 -104.17 REMARK 500 ASP A 192 8.08 -66.88 REMARK 500 ASP A 200 85.31 54.97 REMARK 500 VAL A 214 -97.84 -49.95 REMARK 500 SER A 215 -64.53 -160.69 REMARK 500 TYR A 216 126.00 -34.63 REMARK 500 ILE A 217 -156.16 170.93 REMARK 500 CYS A 218 -152.36 30.47 REMARK 500 ARG A 220 -80.34 -59.58 REMARK 500 ALA A 231 -167.45 -75.85 REMARK 500 THR A 232 -10.15 -171.35 REMARK 500 LEU A 252 -22.07 -144.02 REMARK 500 GLN A 254 146.52 177.07 REMARK 500 PHE A 257 75.06 -118.41 REMARK 500 PRO A 258 -133.09 -53.27 REMARK 500 VAL A 272 -68.55 -104.46 REMARK 500 ASN A 285 -46.16 102.50 REMARK 500 PRO A 286 139.74 -26.14 REMARK 500 TYR A 288 61.93 -65.38 REMARK 500 LYS A 292 80.67 -172.80 REMARK 500 PRO A 294 95.79 -35.68 REMARK 500 PRO A 300 139.41 -21.17 REMARK 500 PRO A 307 -10.82 -48.27 REMARK 500 THR A 326 21.31 -72.94 REMARK 500 SER A 338 -28.52 -37.81 REMARK 500 VAL A 348 97.54 -66.57 REMARK 500 REMARK 500 THIS ENTRY HAS 57 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HBM A 0 DBREF 2O5K A 29 393 UNP P49841 GSK3B_HUMAN 29 393 SEQADV 2O5K MET A 22 UNP P49841 EXPRESSION TAG SEQADV 2O5K HIS A 23 UNP P49841 EXPRESSION TAG SEQADV 2O5K HIS A 24 UNP P49841 EXPRESSION TAG SEQADV 2O5K HIS A 25 UNP P49841 EXPRESSION TAG SEQADV 2O5K HIS A 26 UNP P49841 EXPRESSION TAG SEQADV 2O5K HIS A 27 UNP P49841 EXPRESSION TAG SEQADV 2O5K HIS A 28 UNP P49841 EXPRESSION TAG SEQRES 1 A 372 MET HIS HIS HIS HIS HIS HIS SER ARG ASP LYS ASP GLY SEQRES 2 A 372 SER LYS VAL THR THR VAL VAL ALA THR PRO GLY GLN GLY SEQRES 3 A 372 PRO ASP ARG PRO GLN GLU VAL SER TYR THR ASP THR LYS SEQRES 4 A 372 VAL ILE GLY ASN GLY SER PHE GLY VAL VAL TYR GLN ALA SEQRES 5 A 372 LYS LEU CYS ASP SER GLY GLU LEU VAL ALA ILE LYS LYS SEQRES 6 A 372 VAL LEU GLN ASP LYS ARG PHE LYS ASN ARG GLU LEU GLN SEQRES 7 A 372 ILE MET ARG LYS LEU ASP HIS CYS ASN ILE VAL ARG LEU SEQRES 8 A 372 ARG TYR PHE PHE TYR SER SER GLY GLU LYS LYS ASP GLU SEQRES 9 A 372 VAL TYR LEU ASN LEU VAL LEU ASP TYR VAL PRO GLU THR SEQRES 10 A 372 VAL TYR ARG VAL ALA ARG HIS TYR SER ARG ALA LYS GLN SEQRES 11 A 372 THR LEU PRO VAL ILE TYR VAL LYS LEU TYR MET TYR GLN SEQRES 12 A 372 LEU PHE ARG SER LEU ALA TYR ILE HIS SER PHE GLY ILE SEQRES 13 A 372 CYS HIS ARG ASP ILE LYS PRO GLN ASN LEU LEU LEU ASP SEQRES 14 A 372 PRO ASP THR ALA VAL LEU LYS LEU CYS ASP PHE GLY SER SEQRES 15 A 372 ALA LYS GLN LEU VAL ARG GLY GLU PRO ASN VAL SER TYR SEQRES 16 A 372 ILE CYS SER ARG TYR TYR ARG ALA PRO GLU LEU ILE PHE SEQRES 17 A 372 GLY ALA THR ASP TYR THR SER SER ILE ASP VAL TRP SER SEQRES 18 A 372 ALA GLY CYS VAL LEU ALA GLU LEU LEU LEU GLY GLN PRO SEQRES 19 A 372 ILE PHE PRO GLY ASP SER GLY VAL ASP GLN LEU VAL GLU SEQRES 20 A 372 ILE ILE LYS VAL LEU GLY THR PRO THR ARG GLU GLN ILE SEQRES 21 A 372 ARG GLU MET ASN PRO ASN TYR THR GLU PHE LYS PHE PRO SEQRES 22 A 372 GLN ILE LYS ALA HIS PRO TRP THR LYS VAL PHE ARG PRO SEQRES 23 A 372 ARG THR PRO PRO GLU ALA ILE ALA LEU CYS SER ARG LEU SEQRES 24 A 372 LEU GLU TYR THR PRO THR ALA ARG LEU THR PRO LEU GLU SEQRES 25 A 372 ALA CYS ALA HIS SER PHE PHE ASP GLU LEU ARG ASP PRO SEQRES 26 A 372 ASN VAL LYS LEU PRO ASN GLY ARG ASP THR PRO ALA LEU SEQRES 27 A 372 PHE ASN PHE THR THR GLN GLU LEU SER SER ASN PRO PRO SEQRES 28 A 372 LEU ALA THR ILE LEU ILE PRO PRO HIS ALA ARG ILE GLN SEQRES 29 A 372 ALA ALA ALA SER THR PRO THR ASN HET HBM A 0 34 HETNAM HBM 2-(2,4-DICHLORO-PHENYL)-7-HYDROXY-1H-BENZOIMIDAZOLE-4- HETNAM 2 HBM CARBOXYLIC ACID [2-(4-METHANESULFONYLAMINO-PHENYL)- HETNAM 3 HBM ETHYL]-AMIDE HETSYN HBM 2-(2,4-DICHLOROPHENYL)-4-HYDROXY-N-(2-{4- HETSYN 2 HBM [(METHYLSULFONYL)AMINO]PHENYL}ETHYL)-1H-BENZIMIDAZOLE- HETSYN 3 HBM 7-CARBOXAMIDE FORMUL 2 HBM C23 H20 CL2 N4 O4 S HELIX 1 1 ASN A 95 LEU A 104 1 10 HELIX 2 2 THR A 138 SER A 147 1 10 HELIX 3 3 ARG A 148 LYS A 150 5 3 HELIX 4 4 PRO A 154 PHE A 175 1 22 HELIX 5 5 LYS A 183 GLN A 185 5 3 HELIX 6 6 ALA A 224 PHE A 229 1 6 HELIX 7 7 SER A 236 LEU A 250 1 15 HELIX 8 8 SER A 261 GLY A 274 1 14 HELIX 9 9 THR A 277 MET A 284 1 8 HELIX 10 10 PRO A 300 PHE A 305 1 6 HELIX 11 11 PRO A 310 ARG A 319 1 10 HELIX 12 12 THR A 324 ARG A 328 5 5 HELIX 13 13 THR A 330 ALA A 336 1 7 HELIX 14 14 HIS A 337 PHE A 339 5 3 HELIX 15 15 PHE A 340 ASP A 345 1 6 HELIX 16 16 THR A 363 SER A 368 1 6 HELIX 17 17 ASN A 370 PRO A 372 5 3 HELIX 18 18 LEU A 373 ILE A 378 1 6 SHEET 1 A 6 THR A 38 ALA A 42 0 SHEET 2 A 6 GLN A 52 VAL A 61 -1 O VAL A 54 N VAL A 40 SHEET 3 A 6 TYR A 71 LEU A 75 -1 O LYS A 74 N THR A 57 SHEET 4 A 6 LEU A 81 GLN A 89 -1 O ILE A 84 N TYR A 71 SHEET 5 A 6 VAL A 126 ASP A 133 -1 O VAL A 126 N GLN A 89 SHEET 6 A 6 LEU A 112 SER A 118 -1 N SER A 118 O TYR A 127 SHEET 1 B 2 ILE A 177 CYS A 178 0 SHEET 2 B 2 LYS A 205 GLN A 206 -1 O LYS A 205 N CYS A 178 SHEET 1 C 2 LEU A 187 LEU A 189 0 SHEET 2 C 2 LEU A 196 LEU A 198 -1 O LYS A 197 N LEU A 188 SITE 1 AC1 13 ILE A 62 ALA A 83 ASP A 133 TYR A 134 SITE 2 AC1 13 VAL A 135 PRO A 136 TYR A 140 ARG A 141 SITE 3 AC1 13 GLN A 185 ASN A 186 LEU A 188 ASP A 200 SITE 4 AC1 13 ARG A 220 CRYST1 70.940 72.632 81.795 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014096 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013768 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012226 0.00000